Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT07118059
Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial (TREAT 3)
Effects of Adjunct Omega-3 Long-chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patients: An Early Bactericidal Activity and Inflammatory Activity Trial
Sponsor: North-West University, South Africa
Conditions
Clinical Outcomes Inflammation Biomarkers Iron Status Liver Function Tests Metabolomics Nutritional Status Tuberculosis
Interventions
Omega-3 (EPA+DHA) Placebo
Updated 1 time since 2025 Last updated: Aug 4, 2025 Started: Aug 31, 2025 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Clinical Outcomes and Inflammation Biomarkers, this trial is actively recruiting participants. The trial is conducted by North-West University, South Africa and has accumulated 1 data snapshot since 2025. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- North-West University, South Africa
- Perinatal HIV Research Unit of the University of the Witswatersrand
Data source: North-West University, South Africa
For direct contact, visit the study record on ClinicalTrials.gov .